Dr Lisa Devine discusses the implications of a case-control study conducted in France that assessed the risk of intracranial meningioma associated with progestogen use.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page